• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P-糖蛋白表达水平对药物浓度依赖性细胞膜通透性的影响。

Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane.

作者信息

Shirasaka Yoshiyuki, Sakane Toshiyasu, Yamashita Shinji

机构信息

Faculty of Pharmaceutical Sciences, Setsunan University, 45-1, Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan.

出版信息

J Pharm Sci. 2008 Jan;97(1):553-65. doi: 10.1002/jps.21114.

DOI:10.1002/jps.21114
PMID:17828734
Abstract

The purpose of this study is to develop a kinetic model that can predict the in vivo absorption of P-glycoprotein (P-gp) substrates from in vitro data. Apical (AP) to basal (BL) absorptive permeability of typical P-gp substrate drugs including quinidine, verapamil, vinblastine, and digoxin, were measured in several cell monolayers with different levels of P-gp expression, normal, P-gp induced, P-gp highly induced and MDR1-knockdown Caco-2 cells and MDR1-MDCKII cells. In all cell monolayers, AP to BL permeability of P-gp substrates increased when their AP concentration was increased, showing a sigmoid-type relationship to donor (AP) concentrations. At the higher concentration range, permeability reached a maximum value, suggesting saturation of P-gp-mediated efflux, and at the lower concentration range, permeability decreased depending on P-gp expression level. A simple kinetic model was applied to the permeability-concentration curve of each drug to obtain the fundamental parameters for P-gp-mediated transport, K(m(app)) and V(max). Both K(m(app)) and V(max) of each drug were found to show linear correlations with expression level of P-gp. This study clearly demonstrated the possibility to estimate the permeability of P-gp substrate drugs in human intestine from the expression level of P-gp, and thus the possibility to predict oral absorption of those drugs.

摘要

本研究的目的是建立一个动力学模型,该模型能够根据体外数据预测P-糖蛋白(P-gp)底物的体内吸收情况。在几种具有不同P-gp表达水平的细胞单层中,即正常、P-gp诱导、P-gp高度诱导以及MDR1基因敲除的Caco-2细胞和MDR1-MDCKII细胞中,测定了包括奎尼丁、维拉帕米、长春碱和地高辛在内的典型P-gp底物药物从顶端(AP)到基底(BL)的吸收通透性。在所有细胞单层中,当P-gp底物的AP浓度增加时,其从AP到BL的通透性增加,呈现出与供体(AP)浓度的S型关系。在较高浓度范围内,通透性达到最大值,表明P-gp介导的外排饱和;在较低浓度范围内,通透性根据P-gp表达水平而降低。将一个简单的动力学模型应用于每种药物的通透性-浓度曲线,以获得P-gp介导转运的基本参数,即米氏常数(K(m(app)))和最大转运速率(V(max))。发现每种药物 的K(m(app))和V(max)均与P-gp的表达水平呈线性相关。本研究清楚地证明了根据P-gp的表达水平估算P-gp底物药物在人肠道中通透性的可能性,从而也证明了预测这些药物口服吸收情况的可能性。

相似文献

1
Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane.P-糖蛋白表达水平对药物浓度依赖性细胞膜通透性的影响。
J Pharm Sci. 2008 Jan;97(1):553-65. doi: 10.1002/jps.21114.
2
Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.体外膜通透性的标度以预测体内P-糖蛋白介导的药物吸收
Drug Metab Dispos. 2008 May;36(5):916-22. doi: 10.1124/dmd.107.020040. Epub 2008 Feb 14.
3
Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.由于P-糖蛋白导致低渗透性化合物沿小肠的节段依赖性转运:外排转运在BCS III类药物口服吸收中的作用
Mol Pharm. 2009 Jan-Feb;6(1):19-28. doi: 10.1021/mp800088f.
4
Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.多种P-糖蛋白(P-gp)探针底物的功能评估:细胞系和调节剂浓度对P-gp活性的影响。
Drug Metab Dispos. 2005 Nov;33(11):1679-87. doi: 10.1124/dmd.105.005421. Epub 2005 Aug 10.
5
Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.P-糖蛋白在丹参主要活性成分丹参酮IIA肠道吸收中的作用。
Curr Drug Metab. 2007 May;8(4):325-40. doi: 10.2174/138920007780655450.
6
pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.P-糖蛋白在限制质子化药物肠道吸收中的pH依赖性功能活性:奎尼丁原位外排的动力学分析
J Pharm Sci. 2005 Dec;94(12):2632-43. doi: 10.1002/jps.20489.
7
Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.以MDCKII-MDR1细胞系为模型对肽转运体进行功能表征用于口服吸收研究。
Int J Pharm. 2007 Mar 6;332(1-2):147-52. doi: 10.1016/j.ijpharm.2006.09.056. Epub 2006 Oct 10.
8
Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.P-糖蛋白介导的分泌在药物吸收性通透性中的作用:一种利用被动膜通透性和对P-糖蛋白亲和力的方法。
J Pharm Sci. 1999 Oct;88(10):1067-72. doi: 10.1021/js980378j.
9
Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.P-糖蛋白在限制药物肠道吸收中的功能作用:被动通透性对P-糖蛋白介导的外排转运的贡献。
Mol Pharm. 2005 Jan-Feb;2(1):12-21. doi: 10.1021/mp0499196.
10
Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.人P-糖蛋白在Caco-2细胞中的诱导:一种用于P-糖蛋白介导的药物转运的高灵敏度检测系统的开发。
Drug Metab Pharmacokinet. 2006 Oct;21(5):414-23. doi: 10.2133/dmpk.21.414.

引用本文的文献

1
A Quantitative Model of Chemotherapeutic Drug Sensitivity as a Function of P-Glycoprotein Expression.作为P-糖蛋白表达函数的化疗药物敏感性定量模型。
Molecules. 2025 Jul 18;30(14):3014. doi: 10.3390/molecules30143014.
2
Reliability of in vitro data for the mechanistic prediction of brain extracellular fluid pharmacokinetics of P-glycoprotein substrates in vivo; are we scaling correctly?用于体内P-糖蛋白底物脑细胞外液药代动力学机制预测的体外数据的可靠性;我们的缩放是否正确?
J Pharmacokinet Pharmacodyn. 2025 Feb 8;52(2):16. doi: 10.1007/s10928-025-09963-w.
3
Pharmacogenomics influence on MDR1-associated cancer resistance and innovative drug delivery approaches: advancing precision oncology.
药物基因组学对多药耐药蛋白1相关的癌症耐药性及创新药物递送方法的影响:推进精准肿瘤学发展
Med Oncol. 2025 Feb 6;42(3):67. doi: 10.1007/s12032-025-02611-w.
4
In silico activity and ADMET profiling of phytochemicals from Ethiopian indigenous aloes using pharmacophore models.基于药效基团模型的埃塞俄比亚本土芦荟植物化学成分的虚拟活性和 ADMET 分析。
Sci Rep. 2022 Dec 23;12(1):22221. doi: 10.1038/s41598-022-26446-x.
5
effects of European and Latin-American medicinal plants in CYP3A4 gene expression, glutathione levels, and P-glycoprotein activity.欧洲和拉丁美洲药用植物对CYP3A4基因表达、谷胱甘肽水平和P-糖蛋白活性的影响。
Front Pharmacol. 2022 Oct 5;13:826395. doi: 10.3389/fphar.2022.826395. eCollection 2022.
6
Characterization of Aripiprazole Uptake Transporter in the Blood-Brain Barrier Model hCMEC/D3 Cells by Targeted siRNA Screening.通过靶向 siRNA 筛选鉴定血脑屏障模型 hCMEC/D3 细胞中的阿立哌唑摄取转运体。
Pharm Res. 2022 Jul;39(7):1549-1559. doi: 10.1007/s11095-022-03223-z. Epub 2022 Mar 21.
7
Limited Impact of Murine Placental MDR1 on Fetal Exposure of Certain Drugs Explained by Bypass Transfer Between Adjacent Syncytiotrophoblast Layers.胎盘多药耐药蛋白 1 对某些药物向胎儿暴露的影响有限,这可通过相邻合体滋养层层间旁路转运来解释。
Pharm Res. 2022 Jul;39(7):1645-1658. doi: 10.1007/s11095-022-03165-6. Epub 2022 Jan 26.
8
Starch Nanoparticles for Enhancement of Oral Bioavailability of a Newly Synthesized Thienopyrimidine Derivative with Anti-Proliferative Activity Against Pancreatic Cancer.用于提高新合成的具有抗胰腺癌增殖活性的噻吩并嘧啶衍生物口服生物利用度的淀粉纳米颗粒。
Drug Des Devel Ther. 2021 Jul 16;15:3071-3093. doi: 10.2147/DDDT.S321962. eCollection 2021.
9
Prediction of Drug Clearance from Enzyme and Transporter Kinetics.预测药物清除率的酶和转运体动力学。
Methods Mol Biol. 2021;2342:369-417. doi: 10.1007/978-1-0716-1554-6_14.
10
Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug-Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach.CYP3A4和CYP2B6诱导剂卡马西平的药代动力学及其药物相互作用潜力:基于生理的药代动力学建模方法
Pharmaceutics. 2021 Feb 17;13(2):270. doi: 10.3390/pharmaceutics13020270.